Viewing Study NCT01127750


Ignite Creation Date: 2025-12-24 @ 4:58 PM
Ignite Modification Date: 2026-01-27 @ 11:08 AM
Study NCT ID: NCT01127750
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2010-05-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Tolerability and Safety and Health Outcomes in Relapsing Multiple Sclerosis (MS) Patients
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Relapsing Multiple Sclerosis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsing multiple sclerosis View
None MS View
None safety View
None tolerability View
None health outcomes View